Consistent with this, primary MM cells are particularly addicted to SETD8 activity and the recently developed small-molecule inhibitor of SETD8, UNC-0379, demonstrated a higher toxicity in MM cells compared to normal cells from the bone marrow microenvironment and normal plasma cells (Fig. 2). The gene discussed is KMT5A; the disease is Miyoshi myopathy.